Page last updated: 2024-09-03

ym 529 and Hematologic Malignancies

ym 529 has been researched along with Hematologic Malignancies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imano, M; Itoh, T; Komai, M; Mukai, J; Nishida, S; Ogawa, N; Satou, T; Tsubaki, M1
Fujii, K; Haga, H; Irimajiri, K; Kikuichi, S; Nishida, S; Tsubaki, M; Yoshioka, S1

Other Studies

2 other study(ies) available for ym 529 and Hematologic Malignancies

ArticleYear
Nitrogen-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway.
    Biochemical pharmacology, 2013, Jan-15, Volume: 85, Issue:2

    Topics: Alendronate; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Bone Density Conservation Agents; Cell Line, Tumor; Cell Nucleus; Cell Survival; Diphosphonates; Gene Expression Regulation, Neoplastic; Gene Silencing; Hematologic Neoplasms; Humans; Imidazoles; MAP Kinase Signaling System; Membrane Proteins; Neoplasm Proteins; Protein Kinase Inhibitors; Protein Prenylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Signal Transduction; TOR Serine-Threonine Kinases

2013
Apoptosis-inducing effect of a new bisphosphonate, YM529, on various hematopoietic tumor cell lines.
    Biological & pharmaceutical bulletin, 2003, Volume: 26, Issue:1

    Topics: Apoptosis; Cell Survival; Diphosphonates; Hematologic Neoplasms; HL-60 Cells; Humans; Imidazoles; Intracellular Membranes; Jurkat Cells; K562 Cells; Membrane Potentials; Mitochondria; Tumor Cells, Cultured; U937 Cells

2003